-
Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and KidneysParé G, Bhatt DL. -
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
-
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized TrialG Lemesle, M Laine, M Pankert et al.
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionTardif JC, Kouz S, Waters DD et al.
-
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary SyndromesSzummer K, Jernberg T, Wallentin L.
-
Prevalence and Prognosis of Unrecognized Myocardial Infarction Determined by Cardiac Magnetic Resonance in Older AdultsSchelbert EB, Cao JJ, Schelbert EB1, Arai AE et al.
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
